Navigation Links
SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
Date:4/10/2008

Washington, D.C. (April 10, 2008) Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this weeks New England Journal of Medicine. Carotid artery disease, which involves clogging of the arteries in the neck that provide blood to the brain, is a significant risk factor for stroke, making these study results important for the estimated 200,000 Americans each year who would otherwise not be candidates for the treatment.

The SAPPHIRE trial showed patients undergoing carotid stenting were comparably protected from stroke, heart attack, death, and repeat revascularization procedures as patients who underwent the traditional surgical approach (endarterectomy). SAPPHIRE is the first and longest (three years) randomized study to compare the safety and efficacy of carotid stenting with embolic protection to surgery in high risk patients. High risk patients are considered to be at increased risk for surgery because of prior carotid artery surgery, radiation to the neck, chronic heart failure, lung disease or severe coronary artery disease, among other criteria.

The Society for Cardiovascular Angiography and Interventions (SCAI), the worlds leading society of interventional cardiologists, is encouraged by these positive data. Results are consistent with one-year SAPPHIRE data and echo conclusions from other non-randomized trials supporting the use of carotid stenting, particularly in patients with multiple illnesses.

This is more good news for patients who otherwise might not have treatment options, said Dr. Bonnie Weiner, president of the Society for Cardiovascular Angiography and Interventions. Carotid artery stenting is an effective, safe way to help patients avoid debilitating and potentially fatal strokes. We are hopeful that this news will help pave the way for expanded use of this procedure.

Carotid Artery Stenting

Carot
'/>"/>

Contact: Kathy Boyd David
kbdavid@scai.org
712-422-1181
Society for Cardiovascular Angiography and Interventions
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
2. Stopping a cancer trial early: is it for the benefit of patients or industry?
3. Syndicoms Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems
4. Surgeons announce advance in atrial fibrillation surgery
5. Clinical trial volunteers mostly indifferent -- but not blind to -- researchers financial conflicts
6. Clinical trial will test new HIV/AIDS vaccine
7. Knowing doctors financial interests doesnt deter clinical trial participants
8. Report Claims Clinical Trials Miss Many Populations
9. Renal artery stenting falls short in large randomized trial
10. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
11. Some Cancer Trials Overstate Findings, Analysis Claims

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , CHICAGO, Nov. 20 ...the U.S. Food and Drug Administration (FDA) to est...ning chemicals. ,, Citing concern about the sa...ered without the benefit of professional consultat...aid that the application of chemically based tooth...
(Date:11/20/2009)... , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USN...is on a mission to redefine what it means to be "h...nal counselor with a specialty in family counselin...e Forest University, Gladding says research shows ...ds to sadness and even depression during the holid...
(Date:11/20/2009)...editorial published online November 20 in the Jou...he exaggerated fears and hopes that often appear i...provides guidance for both the media and journals ...z, M.D., M.S., and Steven Woloshin, M.D., M.S., of...h Institute for Health Policy and Clinical Practic...
(Date:11/20/2009)...attle, Washington) November 20, 2009Emergency medi...ssess an estimated 350,000 cardiac arrests each ye...n cardiac arrest survive. Better quality cardiopu...l EMS providers may be associated with better pati...m (ROC) is the largest clinical research network t...
(Date:11/20/2009)...mers save up to one-third buying 90-day supply, st... News) -- Buying a three-month supply of prescript... one-month supply, according to a new study. , ...led for 395 drugs between 2000 and 2005, and found...tead of a one-month supply saved an average 29 per...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2
... field of genetics has been undergoing a revolutio...c mechanisms underlying common disorders and a hug...cific genetic disorders. // This has not onl...breakthrough has been the successful attempts of t...
...hlear implants for ears, which are done in a minim...e following the traditional way. Researchers from ...sent this research finding // at the 109th Annual ... scalp flap, mastoidectomy (a surgical removal of ...
... investigations suggest that treating the problem ...ren join school, can go a long way in curing the c...me out in the latest // edition of BMJ. About...cessary, but evidence to support this is currently...
...earchers from the University of Texas, M.D. Anders... on mutation or damage leads to development of col...efect in this gene leads to // development of colo...ancer. The study was conducted in 95 colorec...
...ox is a wrinkle control cream and a potent neuroto...wrinkles. The product is derived form a bacteria, ...// It is really surprising to note that this ...nction, minute changes that underlie memory and le...
...ing to counter the threat posed by new virus-induc...s, a city-based institute has launched a course of... Institute of // Biotechnology and Bioinformatics ...course is intended to provide qualified virologist...
Other Medicine News:Health News:Launch Of India’s First Virology Course At Pun 2
(Date:11/20/2009)... LONDON, Nov. 20 Boston ...ced that it has received 510(k) clearance from the...rk approval to market its WallFlex® Fully Cov...nt esophageal strictures (obstructions) caused by ...le esophageal cancer. ,, (Photo: http://www....
(Date:11/20/2009)..., Pa., Nov. 20 In respo...tions why currently available medications designed...ed, ECRI Institute, an independent nonprofit organ... Finasteride for Prevention of Prostate Cancer fo...ew York Times article, " Drugs to Deter Some Canc...
(Date:11/20/2009)...Nov. 20 Soligenix, Inc. ...ny), formerly known as DOR BioPharma, Inc., a late... it has formed a consortium to develop thermostabl...y acting vaccines. Soligenix received a $9.4 milli...d Infectious Diseases (NIAID), a division of the N...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 1Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 2Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 3Instrumentation Laboratory Announces Passion 26 Results Award Winners 57753 4Death Panel Inventor 26 Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris 3B Healthcare Industry Today Offers Complete Cove 57751 1Death Panel Inventor 26 Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris 3B Healthcare Industry Today Offers Complete Cove 57751 2Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 1Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 2
...th the OLA2500 High Speed Sorter (HSS) system, ded...ements. As a front-end sample-processor, the OLA25...ample tubes to their destination racks quickly to...rrors. Post-analytical archiving to any archive ra...
COCOON Disposable Paediatric - Neonatal / Child
Bair Hugger® Model 536 - Pediatric Blanket Short
CareQuilt® Pediatric Warming Blanket
Medicine Products: